Gen inCode
GEN inCode is a genetic testing business specialising in the risk assessment and prediction of cardiovascular disease.
Gen inCode has raised €3.8M across 1 funding round from 1 investor, most recently a Growth/Late round in Aug 2020. Based in Manchester, UK; founded 2018; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€3.8M
€3,790,835
Funding rounds
1
Investors
1
distinct backers
Active since
2020-08
latest 2020-08
Funding by year
EUR raised per yearGen inCode — funding by year — interactive chart.
Data table
| Gen inCode — funding by year | |
|---|---|
| 2020 | €3.8M |
Signals
High confidenceRaise-next likelihood7
base rate 37% for Growth/Late
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-08-27 | Growth/Late | €3.8M | Maven Capital Partners | View deal → |